EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieRandomisierte kontrollierte StudieÄquivalenzstudie

A Randomized Comparison of Bioheart Sirolimus-Eluting Bioresorbable Scaffold and Everolimus-Eluting Stents

Shengwen Liu, Shaoping Nie, Yuqing Hou, Guangyong Huang, Guosheng Fu, Hua Zhou, Meng Wei, Feng Lu, Feng Zhang, Lefeng Wang, Yang Wang, Yongjian Wu und 2 weitere

JACC: Cardiovascular Interventions · 2025-01 · 18 (1) · 15-27

DOI: 10.1016/j.jcin.2024.09.043 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025-01. Verfasst von Shengwen Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases of China, Beijing, China. Hauptthemen laut MEDLINE: Absorbable Implants, Everolimus, Drug-Eluting Stents, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Absorbable ImplantsEverolimusDrug-Eluting StentsPercutaneous Coronary InterventionCardiovascular AgentsCoronary Artery DiseaseSirolimusHumansMaleFemaleMiddle AgedProsthesis DesignProspective StudiesTreatment OutcomeTime FactorsAgedChinaRisk FactorsTomography, Optical CoherenceCoronary AngiographyPolyesters

Stichwörter der Autor:innen

bioresorbable scaffold(s)coronary artery diseasenoninferiority trial

Substanzen

EverolimusCardiovascular AgentsSirolimusPolyesterspoly(lactide)

Autor:innen und Institutionen

  • Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases of China, Beijing, China.
  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Cardiology, Liaocheng People's Hospital, Liaocheng, China.
  • Department of Cardiology, Sir Run Run Shaw hospital, Zhejiang University School of Medicine, Zhejiang, China.
  • Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.

Zitieren

APA

Liu, S., Nie, S., Hou, Y., Huang, G., Fu, G., Zhou, H., Wei, M., Lu, F., Zhang, F., Wang, L., Wang, Y., Wu, Y., Qiao, S., & BIOHEART-II Investigators (2025). A Randomized Comparison of Bioheart Sirolimus-Eluting Bioresorbable Scaffold and Everolimus-Eluting Stents. JACC: Cardiovascular Interventions, 18(1), 15-27. https://doi.org/10.1016/j.jcin.2024.09.043

Vancouver

Liu S, Nie S, Hou Y, Huang G, Fu G, Zhou H, et al. A Randomized Comparison of Bioheart Sirolimus-Eluting Bioresorbable Scaffold and Everolimus-Eluting Stents. JACC: Cardiovascular Interventions. 2025;18(1):15-27. doi:10.1016/j.jcin.2024.09.043

BibTeX
@article{Liu2025,
  author = {Liu, Shengwen and Nie, Shaoping and Hou, Yuqing and Huang, Guangyong and Fu, Guosheng and Zhou, Hua and Wei, Meng and Lu, Feng and Zhang, Feng and Wang, Lefeng and Wang, Yang and Wu, Yongjian and Qiao, Shubin and BIOHEART-II Investigators, BIOHEART-II Investigators},
  title = {A Randomized Comparison of Bioheart Sirolimus-Eluting Bioresorbable Scaffold and Everolimus-Eluting Stents},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  volume = {18},
  number = {1},
  pages = {15--27},
  doi = {10.1016/j.jcin.2024.09.043}
}
Kostenlos starten →